COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Attune Pharmaceuticals is a New York City–based biotechnology company developing orally administered small-molecule therapeutics for rare diseases, advancing ATN-249 (oral plasma kallikrein inhibitor) and a complement-mediated disease program.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
